Internet-based Positive Psychological Intervention for Hispanic/Latino Adult With Hypertension in a Primary Care Setting

Sponsor
University of Illinois at Urbana-Champaign (Other)
Overall Status
Unknown status
CT.gov ID
NCT03892057
Collaborator
Rosenfeld Heart Foundation Grant (Other)
70
1
2
25.7
2.7

Study Details

Study Description

Brief Summary

The largest epidemiologic study of Hispanic/Latino participants thus far, i.e., the Hispanic Community Health Study/Study of Latinos (HCHS/SOL) documented that 80% of men and 71% of women have at least one major cardiovascular disease (CVD) risk factor. The American Heart Association emphasizes that current CVD prevention efforts are sparse and ineffectual in minority populations and acknowledges the need for new and more effective disease prevention strategies. This proof-of-concept study and pilot randomized clinical trial seeks to implement and evaluate a novel internet-based 5-week Positive Psychology (PP) Intervention (compared to an attention control condition) in Hispanic/Latino adults with uncontrolled hypertension, i.e., elevated 24-hour ambulatory blood pressure, with primary interest in testing efficacy for clinically meaningful improvements in cardiovascular function.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Internet-based Positive Psychological Intervention
N/A

Detailed Description

The study features piloting of a randomized trial to determine whether an internet-based positive psychology (PP) intervention is associated with greater improvements in blood pressure compared to an attention control condition. The pilot trial additionally evaluates the efficacy of the internet-based PP intervention with respect to psychological well-being, hypertension-related health behaviors, autonomic cardiac control, and high-sensitivity C-reactive protein. Serum blood assays will facilitate exploration of mechanistic indicators linking psychological well-being to cardiac functioning.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Randomized control trialRandomized control trial
Masking:
Single (Outcomes Assessor)
Masking Description:
Outcome assessor will be blind to intervention assignment and will only collect clinical data at baseline, 5-, and 12-weeks.
Primary Purpose:
Treatment
Official Title:
Internet-based Positive Psychological Intervention for Hispanic/Latino Adult With Hypertension in a Primary Care Setting
Actual Study Start Date :
Apr 12, 2019
Anticipated Primary Completion Date :
Jan 1, 2021
Anticipated Study Completion Date :
Jun 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Internet-based Positive Psychological Intervention

The investigator's culturally-tailored internet-based Positive Psychology (PP) Intervention is a non-pharmacotherapy approach aimed at increasing positive emotional experiences by teaching individuals to engage in intentional activities known to increase psychological and emotional well-being through targeting of constructs such as optimism, gratitude, mindfulness/relaxation, and resilience.

Behavioral: Internet-based Positive Psychological Intervention
The investigator's culturally-tailored internet-based Positive Psychology Intervention is a non-pharmacotherapy approach aimed at increasing positive emotional experiences by teaching individuals to engage in intentional activities known to increase psychological and emotional well- being, e.g., mindfulness/meditation. The current 5-week Internet-based intervention will be delivered via a secure website which participants will access at home (or in a public setting with Wi-Fi) using an assigned username and password. The on-line program includes didactic material and "home practice" with participants logging into the website 3-4 times per week for 15 to 20 minute sessions. In addition to weekly on-line instruction, participants are assigned homework as a means of incorporating skills learned into their day-to-day activities.
Other Names:
  • Positive Affect Intervention
  • No Intervention: Attention Control Group

    Participants will complete computerized surveys to document the frequency of positive and negative emotions experienced in daily life. The attention control group will be given the option to access our positive psychological intervention and associated content via the web at the conclusion of the 12-week data collection phase.

    Outcome Measures

    Primary Outcome Measures

    1. Change from Baseline Ambulatory Blood Pressure at 5- and 12-weeks [Baseline, 5-, and 12-weeks]

      The ambulatory blood pressure monitor (the Spacelabs Healthcare 90217A ABPM) will capture 24-hour daytime and nighttime systolic and diastolic blood pressure reading in the natural environment and will capture heart rate variability. The ambulatory blood pressure monitor will record the subject's systolic and diastolic blood pressure periodically every 30 minutes to one hour and the data will be stored in the internal memory until uploaded to a companion application for visualization and analysis. In addition to ambulatory blood pressure the wearable device will record pulse waves on a beat to beat basis from which heart rate variability will be calculated and analyzed.

    Secondary Outcome Measures

    1. Center for Epidemiological Studies Depression Scale: Change from Baseline Depressive Symptoms at 5- and 12-weeks [Baseline, 5-, and 12-weeks]

      Center for Epidemiological Studies Depression-Scale. The total score is computed. Scores range from 0-60, with higher scores indicating greater symptoms of depression.

    2. Life Orientation Test-Revised: Change from Baseline Dispositional Optimism at 5- and 12-weeks [Baseline, 5-, and 12-weeks]

      Life Orientation Test-Revised. Two sub-scale scores are computed for affirming optimism and disaffirming pessimism. Scores range from 0-12 on each sub-scale and summed, with higher scores indicating greater optimism.

    3. General Well-being Schedule: Change in Baseline Emotional Vitality at 5- and 12-weeks [Baseline, 5-, and 12-weeks]

      General Well-being Schedule

    4. Life Engagement Test: Change in Baseline Life engagement and Meaning at 5- and 12-weeks [Baseline, 5-, and 12-weeks]

      Life Engagement Test

    5. Perceived Stress Scale: Change from Baseline Perceived Stress at 5- and 12-weeks [Baseline, 5-, and 12-weeks]

      Perceived Stress Scale. The total score is computed. Scores range from 0 to 16, with higher scores indicating greater perceived stress.

    6. Modified Differential Emotions Scale: Change from Baseline Positive and Negative Affect at 5- and 12-weeks [Baseline, 5-, and 12-weeks]

      Modified Differential Emotions Scale. Two sub-scale scores are computed for positive emotions and negative emotions. The sub-scales are averaged, with higher scores indicating higher positive or negative emotions.

    7. Positive Skills: Change in Baseline Positive Skills at 5- and 12-weeks [Baseline, 5-, and 12-weeks]

      Positive Skills

    8. Medical Outcomes Study Social Support Survey: Change in Baseline Perceived Social Support at 5- and 12-weeks [Baseline, 5-, and 12-weeks]

      Medical Outcomes Study Social Support Survey. Four sub-scale scores are computed for 1) emotional/informational support 2) Tangible support 3) Affectionate Support and 4)Positive Social Interaction. An additional item asks the participant to quantify the number of persons of support. Sub-scale scores range from 1-5, and they are summed for a total score for perceived social support ranging from 0-25, with higher scores indicating greater perceived support.

    9. Medication Adherence: Change in Baseline Medication Adherence at 5- and 12-weeks [Baseline, 5-, and 12-weeks]

      Medication Adherence

    10. 12-Item Short Form Survey: Change in Self-Reported Mental and Physical Health at 5- and 12-weeks [Baseline, 5-, and 12-weeks]

      12-Item Short Form Survey. The total score is computed. Scores range from 0-100, with higher scores indicating greater perceived physical and mental health.

    Other Outcome Measures

    1. Physical Activity: Change in Hypertension-related Health Behavior(s) [Baseline, 5-, and 12-weeks]

      Self-Reported Physical Activity

    2. Diet: Change in Hypertension-related Health Behavior(s) [Baseline, 5-, and 12-weeks]

      Sodium Intake Diet using Scored Sodium Questionnaire. The total score is computed. Scores range from 0-215, with higher scores indicating greater sodium intake.

    3. Change in Heart Rate Variability [Baseline, 5-, and 12-weeks]

      Beat-to-beat interval

    4. Change in High-sensitivity C-Reactive Protein [Baseline, 5-, and 12-weeks]

      mg/L

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Hispanics/Latinos recruited from UI Health Pilsen Family Health Center Lower West

    • Aged ≥18

    • Fluent in English or Spanish with ≥8th grade education

    • Elevated sitting blood pressure (≥140/90)

    • Ability to read and understand the informed consent

    • Ability to access internet from home or in public setting (note, tablet PCs will be made available to all enrolled participants at no charge), and

    • Self-reported comfort in with handling of a table computer and website navigation.

    Exclusion Criteria:
    • Cognitive impairment denoting dementia (assessed using the Short Portable Status Questionnaire-See Appendix E)

    • Severely reduced life expectancy (e.g., self-reported diagnosis of metastatic cancer, congestive heart failure, or end-stage kidney disease)

    • Self-reported diagnosis of sickle cell disease

    • Skin damage or rash in the upper arm region where ambulatory blood pressure monitor is to be placed

    • Currently enrolled in psychotherapy, and

    • Self-reported history or current diagnosis of bipolar disorder, dissociative disorder, psychosis, or substance abuse; or have severe depression.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 UI Health Pilsen Family Health Center Lower West Chicago Illinois United States 60608

    Sponsors and Collaborators

    • University of Illinois at Urbana-Champaign
    • Rosenfeld Heart Foundation Grant

    Investigators

    • Principal Investigator: Rosalba Hernandez, PhD, University of Illinois at Urbana-Champaign

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    University of Illinois at Urbana-Champaign
    ClinicalTrials.gov Identifier:
    NCT03892057
    Other Study ID Numbers:
    • 08776
    First Posted:
    Mar 27, 2019
    Last Update Posted:
    Jul 5, 2019
    Last Verified:
    Jul 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    Yes
    Plan to Share IPD:
    Yes
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by University of Illinois at Urbana-Champaign
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 5, 2019